Serum Lactic Dehydrogenase (LDH) Activity in Lymphomas: Prognostic Significance and Relationship to Presentation, Stage and Histologic Type
Keywords:
Hodgkin's Lymphoma, Non-Hodgkin's lymphoma, LDHAbstract
Background and Objective: Studying the relation of LDH level to presentation, stage and histological subtype of lymphoma and to evaluate its prognostic significance.
Patients and Methods: Hospital records of 13 Hodgkin's and 37 non-Hodgkin's lymphoma patients were reviewed. Patients were followed up; their serum LDH levels were measured after completing therapy. A group of 25 apparently healthy persons matched for age and gender served as controls and their serum LDH levels were measured.
Results: Serum LDH activity was significantly higher in lymphoma patients compared to control group (P <0.001); although none of the Hodgkin's lymphoma patients had serum LDH level above the normal range. Serum LDH activity was not of value in relation to grade and histological subtype of lymphoma, and ESR; but significantly associated with stage of the disease. There was no significant difference in the mean enzyme level among patients who responded and those who not responded to chemotherapy.
Conclusions: Serum LDH level was of no clinical or prognostic significance in Hodgkin's lymphoma. The stage of the disease rather than serum LDH value was the main prognostic marker in non-Hodgkin's lymphoma.
Metrics
References
Abraham NZ Jr, Carty RP, DuFour DR, Pincus MR. Clinical enzymology. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 21st ed. Philadelphia, Pa: Saunders Elsevier; 2006: chap 20.
Flanagan NG, Ridway JC, Rowlands AJ. Lactic dehydrogenase estimation in haematological malignancies. Clin. lab. Haemat 1989; 11,17–26
Bierman HR. Hill BR, Reinbrardt L, Emory E: Correlation of serum lactic dehydrogenase activity with the clinical status of patients with cancer, lymphomas and the leukemias. Cancer Res 1957; 17:660.
Rotenberg Z, Weinberger I, Fuchs Y, Erdberg A, Davidson E, Agmon J. Elevation of serum lactic dehydrogenase levels as an early marker of acute malignant lymphoma. Cancer 1984; 1:1379–81.
Schneider RJ, Seibert K, Passes S, Little C, Gee T, Lee BJ, Mike V, Young CW. Prognostic significance of serum lactate dehydrogenase in malignant lymphoma. Cancer 2006; 46:139–43.
Lehninger A. Organ interrelationships in the metabolism of mammals. In: Lehninger Textbook of Biochemistry, New York:worth, 2000: 829.
Aisenberg A. Coherent view of non-Hodgkin's lymphoma. J Clin Oncol 1995; 13:2656–75.
Garcia R, Hernandez JM, Caballero MD, González M, Galende J, del Caáizo MC, et al. Serum lactate dehydrogenase level as a prognostic factor in Hodgkin's disease. Br J Cancer 1993; 68:1227–71.
De-Vita VT, Molloy-Hubbard S. Hodgkin's disease. N Engl J Med 1993; 328:560–5.
Maloney GD. Non-Hodgkin's lymphoma. Curr Opin Haematol 1995; 2:255–61.
Osterman B, Jonsson H, Tavelin B, Lenner P. Non-Hodgkin's lymphoma in Northern Sweden: Prognostic factors and response to treatment. Acta Oncol 1993; 32: 507–15.
Coiffier, Bastion Y, Berger F, Felman P, Bryon PA. Prognostic factors in follicular lymphomas. Semin Oncol 1993; 20:89–95.
Dawson B, Trapp RG. Basic and Clinical Biostatistics. 4th ed. McGraw-Hill's medical publishing division, 2004.
Jurisic V, Konjevic G, Baicevic, Duricic B, Spuzic I. Different alterations in lactate dehydrogenase activity and profile of peripheral blood mononuclear cell in Hodgkin's and non-Hodgkin's lymphoma. Eur J Haematol 2000; 64:259–66
Al-Saadoon EA, Al-Naama LM, Hassan JK. Serum Lactate Dehydrogenase (LDH) Activity in Childern with Malignant Diseases. Bahrain Medical Bulletin 2003; 25(2):1-7
Martinow JA, Yuen K, Cooper AI, Mathews PJ, Juneja S, Wolf M, et al. Prognostic Marker of Disease Activity in Hodgkin's Disease. Leukemia and lymphoma 1998; 29(3):383–9.
Cowan RA, Jones M, Harris M, Steward WP, Radford JA, Wagstaff J, et al. Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma. Br J Cancer 1999; 59:276–82
Fasola G, Fanin R, Gherlinzoni F, Taruscio D, Frezza G, Mazza P, et al. Serum LDH concentration in non-Hodgkin's lymphoma. Relationship to histologic type, tumor mass and presentation features. Acta Haematol 1984; 72(4):231–8
Dumontet C, Drai J, Bienvenu J, Berard EN, Thieblemont C, Bouafia F et al. Profile and prognostic value of LDH isoenzymes in patients with non-Hodgkin's lymphoma. Leukemia 1999;13:811–17
Downloads
Published
How to Cite
Issue
Section
License
The copyright on any article published in Zanco J Med Sci is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0).
